For clinics that prescribe topical GHK-Cu, the post-May-14 prescribing environment is the same as the pre-April-22 environment, with one practical caveat
[DOI] [PMC free article] [PubMed] [Google Scholar] 33.Fasano A
Metabolic Health Neutral on glucose control: Unlike HGH, AOD-9604 does not negatively impact insulin sensitivity or fasting blood glucose
Known as an anti-inflammatory peptide, it helps repair intestinal tissues and reduce gut inflammation
Thus, it can be hypothesized that the ability of DSIP to maintain efficiency of oxidative phosphorylation, even in the setting of hypoxia, could make the peptide a subject of interest for conditions such as stroke and heart attack in future research
What are we actually trying to fix here